Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mezei

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Developmental Medicine and Child Neurology|April 27, 2011
Expanding the clinical phenotype of the mitochondrial m.13513G>A mutation with the first report of a fatal neonatal presentationClara D M Van Karnebeek, Paula J Waters, Michael A Sargent, et al.
Mitochondrion|April 3, 2020
Self-initiated lifestyle interventions lead to potential insight into an effective, alternative, non-surgical therapy for mitochondrial disease associated multiple symmetric lipomatosisElizabeth Nadeau, Michelle M Mezei, Mark Cresswell, et al.
Orphanet Journal of Rare Diseases|January 11, 2022
Ketogenic diet for mitochondrial disease: potential role in treating the Multiple Symmetric Lipomatosis phenotype associated with the common MT-TK genetic mutationAndre Mattman, Elizabeth Nadeau, Michelle M Mezei, et al.
Neurology|September 25, 1999
Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trialB Kremer, C M Clark, E W Almqvist, et al.
Human Mutation|June 18, 2015
Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype CorrelationsJuan Arredondo, Marian Lara, Sídney M Gospe, et al.
Frontiers in Physiology|March 4, 2025
Loss-of-function mitochondrial DNA polymerase gamma variants cause vascular smooth muscle cells to secrete a diffusible mitogenic factorSamantha Rothwell, Irvin Ng, Sophia Shalchy-Tabrizi, et al.
Mitochondrion|June 6, 2020
High rate of hypertension in patients with m.3243A>G MELAS mutations and POLG variantsAndrew D Pauls, Vikrant Sandhu, Dana Young, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 25, 2021
Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy ManagementMonica Alcantara, Michelle M Mezei, Steven K Baker, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 15, 2020
Response from Authors to the Letter to the EditorJuan Pablo Appendino, Steven Baker, Kristine M Chapman, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 20, 2020
Practice Guidelines for Canadian Neurophysiology Laboratories During the COVID-19 Pandemic, , , et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Developmental Medicine and Child Neurology|April 27, 2011
Expanding the clinical phenotype of the mitochondrial m.13513G>A mutation with the first report of a fatal neonatal presentationClara D M Van Karnebeek, Paula J Waters, Michael A Sargent, et al.
Mitochondrion|April 3, 2020
Self-initiated lifestyle interventions lead to potential insight into an effective, alternative, non-surgical therapy for mitochondrial disease associated multiple symmetric lipomatosisElizabeth Nadeau, Michelle M Mezei, Mark Cresswell, et al.
Orphanet Journal of Rare Diseases|January 11, 2022
Ketogenic diet for mitochondrial disease: potential role in treating the Multiple Symmetric Lipomatosis phenotype associated with the common MT-TK genetic mutationAndre Mattman, Elizabeth Nadeau, Michelle M Mezei, et al.
Neurology|September 25, 1999
Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trialB Kremer, C M Clark, E W Almqvist, et al.
Human Mutation|June 18, 2015
Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype CorrelationsJuan Arredondo, Marian Lara, Sídney M Gospe, et al.
Frontiers in Physiology|March 4, 2025
Loss-of-function mitochondrial DNA polymerase gamma variants cause vascular smooth muscle cells to secrete a diffusible mitogenic factorSamantha Rothwell, Irvin Ng, Sophia Shalchy-Tabrizi, et al.
Mitochondrion|June 6, 2020
High rate of hypertension in patients with m.3243A>G MELAS mutations and POLG variantsAndrew D Pauls, Vikrant Sandhu, Dana Young, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 25, 2021
Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy ManagementMonica Alcantara, Michelle M Mezei, Steven K Baker, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 15, 2020
Response from Authors to the Letter to the EditorJuan Pablo Appendino, Steven Baker, Kristine M Chapman, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 20, 2020
Practice Guidelines for Canadian Neurophysiology Laboratories During the COVID-19 Pandemic, , , et al.
Pageof 10